55827-50-4Relevant articles and documents
MONOACYLGLYCEROL LIPASE INHIBITORS
-
Paragraph 0111-0112; 0141; 0153-0154; 0212-0213, (2021/09/09)
Provided are compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof: Also provided are compositions comprising compounds of formula (I). The compounds and compositions are also provided for use as medicaments, for example as medicaments useful in the treatment of a condition modulated by monoacylglycerol lipase (MAGL). Also provided are the use of compounds and compositions for the inhibition of monoacylglycerol lipase (MAGL).